Melrose Industries PLC

Board/Management Information • Jun 21, 2023

National Storage Mechanism | Additional information

RNS Number : 2972D

Melrose Industries PLC

21 June 2023

21 June 2023

Melrose Industries PLC

Appointment of Independent Non-Executive Director

Melrose Industries plc ("Melrose") is pleased to announce the appointment of Gillian Elcock to its Board as a Non-executive Director with effect from Wednesday 21 June 2023.

Gillian has extensive investment research experience including several years covering aerospace and defence as an analyst at Putnam Investments and Insight Investment. Gillian is also the founder and former Managing Director of Denny Ellison, an independent investment research and training company. She has two engineering degrees from MIT and an MBA from the Harvard Business School, and is currently a Non-executive Director of International Biotechnology Trust plc, and a member of the Board of the CFA UK.

Justin Dowley, Non-executive Chairman of Melrose, said:

"We are delighted to welcome Gillian to the Board. We look forward to benefitting from her broad experience and believe she will make a significant contribution to Melrose as we work to deliver further value for all our stakeholders."

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment.

Enquiries:

Montfort Communications:	+44 (0) 20 3514 0897
Nick Miles, Charlotte McMullen	+44 (0) 7739 701634 / +44 (0) 7921 881 800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAGCGDLGGDDGXG